ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent OpenLab Server and OpenLab ECM XT

Technical notes | 2024 | Agilent TechnologiesInstrumentation
Software
Industries
Other
Manufacturer
Agilent Technologies

Summary

Compliance of Agilent OpenLab Server and OpenLab ECM XT with Title 21 CFR Part 11 and Annex 11


Importance of the Topic


In regulated pharmaceutical environments, maintaining electronic records and signatures in compliance with 21 CFR Part 11 and EU Annex 11 is essential for data integrity, traceability, and audit readiness. Organizations rely on secure systems to ensure records are attributable, legible, contemporaneous, original, and accurate throughout their lifecycle.

Objectives and Overview


This white paper examines how Agilent OpenLab Server and OpenLab ECM XT version 2.8 support compliance with US FDA 21 CFR Part 11 and EU Annex 11 by providing a central, secured repository for both Agilent and non-Agilent data systems. It outlines the division of technical controls implemented by the software supplier and procedural controls required by the user organization.

Methodology and Instrumentation


The compliance framework combines software features with organizational procedures:
  • Technical Controls: validation, role-based access, audit trails capturing Who/What/When/Where/Why, file versioning, checksum verification, automated backup and restore utilities.
  • Procedural Controls: standard operating procedures, change control processes, user training, governance and internal audits.

Used Instrumentation


The solution includes:
  • OpenLab Server 2.8 as a centralized repository for Agilent instrument data.
  • OpenLab ECM XT 2.8 for non-Agilent data sources such as Empower, Microsoft Office files, and PDF documents.
  • Primary applications like OpenLab CDS for data acquisition and processing.

Main Results and Discussion


Mapping against Part 11 and Annex 11 requirements shows that OpenLab Server and ECM XT meet or support key controls through:
  • System Validation: supplier-performed functional testing, complemented by user-driven validation of sample workflows.
  • Security and Access Control: integration with Active Directory for unique credentials, configurable roles, session timeout, and physical safeguards.
  • Electronic Audit Trails: secure, computer-generated, time-stamped logs of record creation, modification and deletion, exportable and printable for review.
  • Electronic Signatures: irreversible linkage of signature metadata (signer name, date/time, signature purpose) to electronic records.
  • Data Handling: generation of accurate human-readable and electronic copies, secure backup and retrieval procedures, integrity checks during storage and transfer.

Benefits and Practical Applications


The integrated platform enables laboratories to:
  • Centralize data management from multiple sources under a validated framework.
  • Reduce compliance risk with automated audit trails and signature controls.
  • Simplify regulatory inspections through readily available reports and exports.
  • Ensure long-term data retention and integrity across system upgrades.

Future Trends and Possibilities


Emerging developments may include:
  • Cloud-based deployments for scalable and distributed data management.
  • Enhanced interoperability with LIMS and Internet of Things (IoT) laboratory devices.
  • Artificial intelligence-driven analytics for proactive data-integrity monitoring.
  • Mobile and remote access solutions with maintained compliance safeguards.

Conclusion


Agilent OpenLab Server and ECM XT provide a robust set of technical controls that, when combined with organizational SOPs and governance, enable laboratories to achieve and maintain readiness for FDA and EU regulatory inspections, safeguarding electronic records and signatures throughout their lifecycle.

Reference


  1. Botha RA, Eloff JHP. Separation of duties for access control enforcement in workflow environments. IBM Systems Journal. 2001;40(3):666-682.
  2. US Food and Drug Administration. Code of Federal Regulations Title 21 Part 11 Electronic Records; Electronic Signatures. 1997.
  3. European Commission. EudraLex Volume 4, Annex 11 Computerized Systems. 2011.
  4. European Commission. Eudralex Volume 4, Good Manufacturing Practice. Annex 11 Computerized Systems.
  5. Agilent Technologies. OpenLab Server and OpenLab ECM XT Administration Guide. 2024.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500
White Paper Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary UV Workstation Software for Cary 3500 Overview US FDA Part 11 in Title 21 of the Code of Federal Regulations (CFR), and its EU analog,…
Key words
yes, yeselectronic, electronicrecords, recordsresponsibility, responsibilityuser, userrecommendation, recommendationusers, userscary, caryorganization, organizationpassword, passwordothers, otherscomments, commentsaudit, auditrequirement, requirementsignatures
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent Cary WinUV Pharma White Paper Overview US FDA Part 11 in Title 21 of the Code of Federal Regulations (CFR), and its EU analog, Eudralex Chapter 4, Annex…
Key words
yes, yeselectronic, electronicrecords, recordsresponsibility, responsibilityuser, userpassword, passwordorganization, organizationsignature, signaturerequirement, requirementaudit, auditothers, otherswinuv, winuvassociated, associatedregulations, regulationssignatures
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software
White Paper Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software Overview US FDA Part 11 in Title 21 of the Code of Federal Regulations (CFR), and its EU analog,…
Key words
yes, yeselectronic, electronicuser, userresponsibility, responsibilityrecords, recordssignatures, signaturespassword, passwordorganization, organizationsignature, signaturerecommendation, recommendationaudit, auditscm, scmassociated, associatedothers, otherscomments
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma
White Paper Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent MicroLab Pharma Overview US FDA Part 11 in Title 21 of the Code of Federal Regulations (CFR), and its EU analog, Eudralex Chapter 4, Annex 11,…
Key words
yes, yeselectronic, electronicuser, userrecords, recordspassword, passwordresponsibility, responsibilityscm, scmmicrolab, microlabsignatures, signaturesaudit, auditorganization, organizationsignature, signaturerecommendation, recommendationusers, usersothers
Other projects
GCMS
LCMS
Follow us
FacebookLinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike